Concerta Industry Insight 2016 with Global API Manufacturers and Market Outlook

Press release   •   Jul 20, 2016 08:00 EDT

The Report “Concerta - Drug Insights, 2016" highlights the Concerta marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers the Global Market Assessment of the Concerta covering the total sales estimation and also provides the Concerta sales performance during the historical period and forecast period to 2018. Report also covers the detailed clinical assessment of Concerta, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, Report provides the SWOT analysis for the Concerta.

Complete Report Spread across 35 pages with 10 Figures Now Available. Get Discount at http://www.rnrmarketresearch.com/contacts/discount?rname=450898


  • A review of the Concerta based on information derived from company and industry-specific sources
  • Coverage of the Marketed data of the Concerta on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
  • Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Concerta with location details
  • Patent Expiry Timeline and Exclusivity Details
  • Route of Synthesis of the API
  • Global Forecasted Sales Figure to 2018
  • Qualitative and quantitative assessment of market space
  • SWOT Analysis

Key Coverage and Benefits

  • Evaluate the marketing status and exclusivity details of Concerta to exploit opportunities for generic drug development opportunities.
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Concerta.
  • API intelligence over Concerta and gaining primary intelligence over Active Ingredients manufacturers across the globe.
  • Understanding the chemical route of synthesis of Concerta.
  • Uncovering opportunities in the rapidly growing the US market
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drug's performance
  • Obtain sales forecast for currently marketed drug for to 2018

Order a Copy of This Report at http://www.rnrmarketresearch.com/contacts/purchase?rname=450898

List of Tables

Table 1: Concerta, Historical Global Sales (in million USD), 2016

Table 2: Concerta, Forecasted Global Sales (in million USD), 2016

Table 3: Concerta, Description

Table 4: Concerta, Marketed Details the United States (US)

Table 5: Concerta, Marketed Details the Europe (EU)

Table 6: Concerta, Patent/Exclusivity Expiry (Year), 2016

Table 7: Concerta, Patent Number Specific Patent Expiry (Year), 2016

Table 8: Concerta, Patent Details

Table 9: Concerta, Route of Synthesis

Table 10: Concerta, the United States Drug Master File (US DMF), 2016

Table 11: Concerta, the Europe Active Substance Master File (ASMF), 2016

Table 12: Concerta, the API Manufacturers, China, 2016

Table 13: Concerta, the API Manufacturers, India, 2016

Table 14: Concerta, Generic Players, 2016

Table 15: Concerta, Pipeline Drug Details, 2016

Table 16: Concerta, Clinical Trials, 2016

Table 17: Concerta, Clinical Trials by Zone, 2016

Table 18: Company Overview, 2016

Table 19: Concerta, SWOT Analysis, 2016

List of Figures

Figure 1: Concerta, Historical Global Sales (in million USD), 2016

Figure 2: Concerta, Forecasted Global Sales (in million USD), 2016

Figure 3: Concerta, Patent/Exclusivity Expiry (Year), 2016

Figure 4: Concerta, Patent Number Specific Patent Expiry (Year), 2016

Figure 5: Concerta, Route of synthesis

Figure 6: Concerta, the API Manufacturers by the US DMF Status (%), 2016

Figure 7: Concerta, the API Manufacturers by Region, 2016

Figure 8: Concerta, the API Manufacturers by Location/Countries, 2016

Figure 9: Concerta, Generic Players, 2016

Figure 10: Concerta, Clinical Trials by Zone (%), 2016

View More Details about This Report at http://www.rnrmarketresearch.com/concerta-drug-insights-2016-market-report.html

About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Us:
We provide 24/7 online and offline support to our customers. Contact us for your special interest needs and we will get in touch within 24hrs to help you find the market research report you need.
+ 1 888 391 5441